Expression of inflammatory cytokines following acute spinal cord injury in a rodent model

Journal of Neuroscience Research

Volumn 90, Issue 4, 2012, Pages 782-790

  Stammers, A T ^a   Liu, J ^a   Kwon, B K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cytokines; Inflammation; Rodent; Spinal cord injury

Indexed keywords

CYTOKINE; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL CORD INJURY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TIME FACTORS;

EID: 84856728400     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22820     Document Type: Article

References (46)

1. Anderson AJ, Robert S, Huang W, Young W, Cotman CW. 2004. Activation of complement pathways after contusion-induced spinal cord injury. J Neurotrauma 21: 1831-1846.
2. Baudrie V, Roullet JB, Goureau Y, Chaouloff F, Elghozi JL. 1990. Determination of cerebrospinal fluid production rate using a push-pull perfusion procedure in the conscious rat. Fundam Clin Pharmacol 4: 269-274.
3. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. 2010. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 133: 433-447.
4. Bethea JR, Nagashima H, Acosta MC, et al. 1999. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16: 851-863.
5. Blight AR. 1985. Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma 2: 299-315.
6. Byrnes KR, Stoica B, Riccio A, Pajoohesh-Ganji A, Loane DJ, Faden AI. 2009. Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann Neurol 66: 63-74.
7. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. 1998. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151: 77-88.
8. Cho DC, Cheong JH, Yang MS, Hwang SJ, Kim JM, Kim CH. 2011. The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury. J Korean Neurosurg Soc 49: 83-91.
9. De Rivero Vaccari J, V Lotocki G, Marcillo AE, Dietrich WD, Keane RW. 2008. A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci 28: 3404-3414.
10. Ditor DS, Bao F, Chen Y, Dekaban GA, Weaver LC. 2006. A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury. J Neurosurg Spine 5: 343-352.
11. Dusart I, Schwab ME. 1994. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6: 712-724.
12. Edsbagge M, Tisell M, Jacobsson L, Wikkelso C. 2004. Spinal CSF absorption in healthy individuals. Am J Physiol Regul Integr Comp Physiol 287: R1450-R1455.
13. Fawcett JW, Curt A, Steeves JD, et al. 2007. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45: 190-205.
14. Fehlings MG, Baptiste DC. 2005. Current status of clinical trials for acute spinal cord injury. Injury 36( Suppl 2): B113-B122.
15. Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA. 2006. Minocycline neuroprotects, reduces microgliosis, inhibits caspase protease expression early after spinal cord injury. J Neurochem 97: 1314-1326.
16. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. 1999. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 19: 8182-8198.
17. Fleming JC, Bao F, Chen Y, Hamilton EF, Relton JK, Weaver LC. 2008. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp Neurol 214: 147-159.
18. Fu ES, Saporta S. 2005. Methylprednisolone inhibits production of interleukin-1beta and interleukin-6 in the spinal cord following compression injury in rats. J Neurosurg Anesthesiol 17: 82-85.
19. Harrington JF, Messier AA, Levine A, Szmydynger-Chodobska J, Chodobski A. 2005. Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma 22: 919-928.
20. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. 2008. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 25: E14.
21. Jackson CA, Messinger J, Peduzzi JD, Ansardi DC, Morrow CD. 2005. Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10. Virology 336: 173-183.
22. Jones TB, McDaniel EE, Popovich PG. 2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11: 1223-1236.
23. Kwon BK, Stammers AM, Belanger LM, et al. 2010. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma 27: 669-682.
24. Kwon BK, Casha S, Hurlbert RJ, Yong VW. 2011. Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin Chem Lab Med 49: 425-433.
25. Last RJ, Tompsett DH. 1953. Casts of the cerebral ventricles. Br J Surg 40: 525-543.
26. Lee YL, Shih K, Bao P, Ghirnikar RS, Eng LF. 2000. Cytokine chemokine expression in contused rat spinal cord. Neurochem Int 36: 417-425.
27. Mann C, Lee JH, Liu J, et al. 2008. Delayed treatment of spinal cord injury with erythropoietin or darbepoetin-a lack of neuroprotective efficacy in a contusion model of cord injury. Exp Neurol 211: 34-40.
28. McTigue DM, Tani M, Krivacic K, et al. 1998. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res 53: 368-376.
29. Ousman SS, David S. 2001. MIP-1alpha, MCP-1, GM-CSF, TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21: 4649-4656.
30. Popovich PG, Reinhard JFJr, Flanagan EM, Stokes BT. 1994. Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res 633: 348-352.
31. Popovich PG, Wei P, Stokes BT. 1997. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377: 443-464.
32. Pouw MH, Hosman AJ, van Middendorp JJ, Verbeek MM, Vos PE, van de Meent H. 2009. Biomarkers in spinal cord injury. Spinal Cord 47: 519-525.
33. Ramer MS, Harper GP, Bradbury EJ. 2000. Progress in spinal cord research-a refined strategy for the International Spinal Research Trust. Spinal Cord 38: 449-472.
34. Stirling DP, Khodarahmi K, Liu J, et al. 2004. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24: 2182-2190.
35. Tian DS, Xie MJ, Yu ZY, et al. 2007. Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Brain Res 1135: 177-185.
36. Tonai T, Taketani Y, Ueda N, et al. 1999. Possible involvement of interleukin-1 in cyclooxygenase-2 induction after spinal cord injury in rats. J Neurochem 72: 302-309.
37. Tonai T, Shiba K, Taketani Y, et al. 2001. A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J Neurochem 78: 1064-1072.
38. Trivedi A, Olivas AD, Noble-Haeusslein LJ. 2006. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res 6: 283-292.
39. Ueno T, Ohori Y, Ito J, et al. 2011. Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. Spinal Cord 49: 333-336.
40. Wang CX, Olschowka JA, Wrathall JR. 1997. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 759: 190-196.
41. Wang XJ, Kong KM, Qi WL, Ye WL, Song PS. 2005. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol Sin 26: 934-942.
42. Xu WB, Lu G, Wang YF, et al. 2009. Combination of dexamethasone and aminoguanidine reduces secondary damage in compression spinal cord injury. Cell Mol Neurobiol 29: 683-689.
43. Yang L, Jones NR, Blumbergs PC, et al. 2005. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 12: 276-284.
44. Yune TY, Lee JY, Jung GY, et al. 2007. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27: 7751-7761.
45. Zhang Z, Krebs CJ, Guth L. 1997. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response. Exp Neurol 143: 141-152.
46. Zhou Z, Peng X, Insolera R, Fink DJ, Mata M. 2009. IL-10 promotes neuronal survival following spinal cord injury. Exp Neurol 220: 183-190.